Navidea Biopharmaceuticals, Inc. SC 13D and SC 13D/A reports

Location
4995 Bradenton Avenue, Suite 240, Dublin, OH
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/19/2024, 08:54 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Feb 5, 2024
SC 13D/A Report SC 13D/A Dec 21, 2023
SC 13D/A Report SC 13D/A Jul 5, 2023
SC 13D/A Report SC 13D/A Jun 16, 2023
SC 13D/A Report SC 13D/A Sep 22, 2022
SC 13D/A Report SC 13D/A Sep 14, 2022
SC 13D/A Report SC 13D/A Sep 12, 2022
SC 13D/A Report SC 13D/A Apr 22, 2022
SC 13D/A Report SC 13D/A Jul 23, 2021
SC 13D/A Report SCHEDULE 13D/A Jun 15, 2021
SC 13D/A Report SC 13D/A Apr 5, 2021
SC 13D/A Report SC 13D/A Mar 11, 2021
SC 13D/A Report SC 13D/A Mar 5, 2021
SC 13D/A Report SC 13D/A Dec 29, 2020
SC 13D/A Report SC 13D/A Sep 2, 2020
SC 13D/A Report SC 13D/A Feb 26, 2020
SC 13D/A Report SC 13D/A Dec 12, 2019
SC 13D Report SC 13D Jun 24, 2019
SC 13D/A Report Jun 28, 2016
SC 13D/A Report May 4, 2016
SC 13D/A Report | Data SC 13D/A Apr 12, 2016
SC 13D/A Report SC 13D/A Mar 18, 2016
SC 13D Report SC 13D Mar 9, 2016
SC 13D/A Report NOVEMBER 15, 2013 Nov 18, 2013
SC 13D/A Report PLATINUM-MONTAUR LIFE SCIENCES, LLC SC 13DA #2 4-2-2012 (NAVIDEA BIOPHARMACEUTIC Jun 4, 2012
SC 13D/A Report APRIL 20, 2011 Apr 21, 2011
SC 13D Report MARCH 18, 2011 Mar 18, 2011